National estimate of multiple sclerosis incidence in France (2001-2007)

A Fromont1, C Binquet, Ea Sauleau

  • 1Department of Neurology, University Hospital of Dijon, France.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 3, 2012
PubMed
Abstract

Insights

This study estimates multiple sclerosis (MS) incidence in France, finding higher rates in women and northeastern regions. These findings provide crucial data for understanding MS prevalence and geographic variations across the nation.

Area of Science:

  • Epidemiology
  • Neurology
  • Public Health

Background:

  • Multiple Sclerosis (MS) is a significant long-term illness in France, with its incidence and geographic distribution previously unknown.
  • Understanding MS incidence is vital as it is one of the 30 illnesses fully covered by French healthcare.

Purpose of the Study:

  • To estimate the national incidence of Multiple Sclerosis (MS) in France.
  • To analyze the geographic variations in MS incidence across different regions of France.

Main Methods:

  • Utilized data from the main French health insurance system, covering 87% of the population from November 2000 to October 2007.
  • Calculated the national MS notification rate and its confidence interval.
  • Employed a Bayesian approach to analyze geographic variations in MS incidence.

Main Results:

  • An age-standardized MS notification rate of 6.8 per 100,000 was observed.
  • Higher incidence rates were noted in women (9.8 per 100,000) compared to men (3.7 per 100,000).
  • Geographic analysis revealed higher MS notification rates in northeastern France, with lower rates along the Atlantic coast, in the Alps, and along the Rhône River.

Conclusions:

  • This study provides the first national estimates of Multiple Sclerosis incidence in France for the period 2000-2007.
  • The findings highlight significant geographic variations in MS incidence within France.
  • The data offers a foundation for further epidemiological research and public health strategies concerning MS.